Family Office Briefing on research bySavills·Apr 11, 2025
The Life Sciences Tenant Q1 2025
Life sciences funding faces challenges in Q1 2025 — family offices should consider co-GP opportunities with resilient operators.
Life ScienceQ1 2025
Quantitative metrics for this report are published by Savills in the full report. Read it directly below for the underlying data tables.
Full report
Savills
Building a thesis around Life Science? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.